Does Mounjaro Affect Blood Pressure — and What Should You Expect?

Blood pressure often decreases gradually as weight falls during tirzepatide treatment, a secondary benefit observed consistently in the SURMOUNT trials.
Some people experience a short-lived dip in blood pressure, particularly early in treatment or around dose increases, which can cause light-headedness on standing.
Tirzepatide does not sharply raise blood pressure; any transient increases are rare and discussed in the context of the whole cardiovascular picture.
If you take antihypertensive medicines, your GP or prescriber may need to review your doses as your weight and blood pressure change on treatment.

Mounjaro (tirzepatide) can affect blood pressure, and for most people the change is a reduction. Clinical trials and real-world data show that as body weight falls on tirzepatide treatment, blood pressure tends to fall with it — a meaningful benefit for people who started treatment with hypertension. The effect is gradual rather than sudden, and it is not guaranteed for everyone. Mounjaro is a prescription-only medicine; a GPhC-registered prescriber assesses whether it is clinically appropriate for you before any treatment begins. If you have a blood pressure condition, or take medicines for one, that forms part of the clinical picture your prescriber reviews.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

How tirzepatide interacts with your blood pressure: the decision points to understand

The most common direction: blood pressure tends to fall

When people ask how Mounjaro affects blood pressure, the most evidence-backed answer is: it usually brings it down. That outcome is largely driven by weight loss itself. Carrying excess weight is one of the strongest modifiable contributors to raised blood pressure, and as tirzepatide reduces body weight (by an average of around 20% at the highest dose across clinical trials) systolic and diastolic readings tend to follow.

The SURMOUNT-1 trial, published in the New England Journal of Medicine, enrolled thousands of adults with obesity and documented meaningful reductions in systolic blood pressure alongside the primary weight outcomes. These were not trivial numbers: participants with hypertension at baseline often saw clinically relevant falls over the 72-week period. For a fuller picture of how tirzepatide's blood-pressure-reducing effect has been characterised in research, that page covers the evidence in depth.

The practical implication is that if you start treatment with blood pressure that is borderline or already medicated, your readings genuinely may improve. That is a benefit, but it does require monitoring, because a reduction that was welcome at one point can become too large a drop if your antihypertensive prescription is not adjusted alongside it.

A separate question: does tirzepatide ever raise blood pressure?

This is the part people worry about less often but worth addressing directly. There is no consistent signal from clinical trials that Mounjaro raises blood pressure in any sustained way. Heart rate can tick up modestly with GLP-1 receptor agonists as a class effect, but the blood-pressure picture for tirzepatide specifically has remained reassuring across the SURMOUNT programme.

Transient fluctuations can happen (as they can with any physiological change) and dehydration from gastrointestinal side effects such as nausea or vomiting, which are most common in the first weeks of treatment or after a dose increase, can temporarily affect readings. Staying well hydrated matters. The NHS tirzepatide patient information page describes dizziness as a known side effect, which in some cases reflects a transient fall in blood pressure rather than a rise. Our page on whether Mounjaro raises blood pressure sets out this distinction more fully for anyone whose concern runs in that direction.

If you have pre-existing cardiovascular disease, that is exactly the kind of detail a prescriber weighs before recommending treatment. It does not automatically exclude you, but it shapes the clinical picture.

Low blood pressure as a side effect, what to watch for

A smaller group of people experience the opposite concern: blood pressure that drops low enough to cause symptoms. Light-headedness when standing up quickly, sometimes called postural hypotension, is the most common presentation. It can occur early in treatment, particularly if you are also taking medicines that lower blood pressure, ACE inhibitors, ARBs, calcium channel blockers, or diuretics among them.

One practical habit that takes under a minute: sit on the edge of your bed or chair for a few seconds before standing, especially in the morning or after a long rest. It gives your circulation a moment to adjust. If standing up regularly makes you dizzy or faint, that is a conversation to have with your prescriber rather than something to wait out. Our dedicated page on Mounjaro and low blood pressure covers this scenario in more detail.

People who find tirzepatide has worked well for their weight but are noticing symptoms worth reviewing can also read about how Mounjaro may help with blood pressure over the longer term, alongside what to report and when.

What this means for the decision you are actually facing

If you are weighing up whether tirzepatide is right for you (and blood pressure is part of that picture) the question is not simply whether the medicine affects it, but how the net effect lands for your individual cardiovascular profile. For most people, the trajectory is positive. For people already on multiple blood-pressure medicines, the benefit comes with a monitoring requirement.

A prescriber cannot make that call without seeing the full picture: your current readings, your medications list, and your medical history. That is precisely what the clinical consultation at nume is designed to gather. Every consultation is read by a real prescriber on the same day (a clinician, not an automated process) and blood-pressure-related medicines are explicitly part of the safety review. You can explore what tirzepatide treatment involves on our tirzepatide overview page, see a broader comparison of options on our weight-loss treatments page, or read more about Mounjaro before deciding. If cost is a factor in your thinking, our Mounjaro price comparison guide sets out what private treatment actually includes.

Ready to have your full medical picture reviewed? Speak to our prescribers by starting a free consultation, no waiting list, no referral needed.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions